The CCRA Advisory Board Welcomes Dr. Don Desserud
Effective January 1, 2020, Dr. Don Desserud begins his term as the Patient/Family Representative on the CCRA Advisory Board. Dr. Desserud participated in the 2019 Patient Involvement in Cancer Research Project (PIP) and is a survivor of Non-Hodgkin Lymphoma.
Dr. Desserud is a Political Science professor and researcher at the University of Prince Edward Island. He is very familiar with peer review and the research funding landscape in Canada. He also serves on three other boards: the Quality Assurance Committee at the Canadian Partnership Against Cancer, Health PEI’s Cancer Strategy Coordination Committee, and the PEI Electronic Synoptic Pathology Reporting Initiative (ESPRI) Committee.
We welcome Dr. Desserud and look forward to the contribution he will make to the CCRA going forward.
New Members Join the Alliance
The CCRA is pleased to announce the addition of two new member organizations: Bladder Cancer Canada and Myeloma Canada, and we welcome new representatives: Michelle Colero, Executive Director, Bladder Cancer Canada and Martine Elias, Executive Director, Myeloma Canada.
... Read More »
The CCRA is pleased to announce the addition of two new member organizations: Bladder Cancer Canada and Myeloma Canada, and we welcome new representatives: Michelle Colero, Executive Director, Bladder Cancer Canada and Martine Elias, Executive Director, Myeloma Canada.
... Read More »
Open Call for Research Proposals for BioCanRx
BioCanRx, Canada’s Immunotherapy Network, is launching its first Open Call for Research Proposals, made possible by funding from the Strategic Science Fund. By funding the selected proposals, BioCanRx will increase support for multi-disci... Read More »
BioCanRx, Canada’s Immunotherapy Network, is launching its first Open Call for Research Proposals, made possible by funding from the Strategic Science Fund. By funding the selected proposals, BioCanRx will increase support for multi-disci... Read More »